BRPI0408675A - derivados de talidomida solúveis em água - Google Patents

derivados de talidomida solúveis em água

Info

Publication number
BRPI0408675A
BRPI0408675A BRPI0408675-9A BRPI0408675A BRPI0408675A BR PI0408675 A BRPI0408675 A BR PI0408675A BR PI0408675 A BRPI0408675 A BR PI0408675A BR PI0408675 A BRPI0408675 A BR PI0408675A
Authority
BR
Brazil
Prior art keywords
chr
water soluble
thalidomide derivatives
alkyl
soluble thalidomide
Prior art date
Application number
BRPI0408675-9A
Other languages
English (en)
Inventor
Hesheng Zhang
Original Assignee
Tian Jin Hemay Bio Tech Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tian Jin Hemay Bio Tech Co Ltd filed Critical Tian Jin Hemay Bio Tech Co Ltd
Publication of BRPI0408675A publication Critical patent/BRPI0408675A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/08—Antibacterial agents for leprosy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Otolaryngology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Artificial Filaments (AREA)

Abstract

"DERIVADOS DE TALIDOMIDA SOLúVEIS EM AGUA". Trata-se de novos derivados de talidomida (I) e suas bases ou sais: em que R representa CHR¬ 1¬NR¬ 2¬R¬ 3¬, CHR¬ 1¬NR¬ 4¬C(O)CHR¬ 5¬NR¬ 2R¬ 3¬ W ou CHR¬ 5¬NR¬ 4¬C(O)W, em que R¬ 1¬, R¬ 4¬ e R¬ 5¬ representam, independentemente um do outro, H, C ~1-4~ alquila, R¬ 2¬ é uma C~ 1-4~ alquila, R¬ 3¬ é uma C~ 1-4~ alquila, ou R¬ 2¬ e R¬ 3¬ representam conjuntamente 1,3-propileno, 1,4-butileno, 1,5-pentileno, 1,6-hexileno, W representa um heterociclo de quatro, cinco, seis, sete ou oito membros, saturado ou insaturado. A invenção também se refere a processos para a sua produção e ao seu uso como um ingrediente farmacêutico ativo.
BRPI0408675-9A 2003-03-27 2004-03-04 derivados de talidomida solúveis em água BRPI0408675A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CNB031209947A CN100488959C (zh) 2003-03-27 2003-03-27 水溶性的酞胺哌啶酮衍生物
PCT/CN2004/000167 WO2004085422A1 (en) 2003-03-27 2004-03-04 Water-soluble thalidomine derivatives

Publications (1)

Publication Number Publication Date
BRPI0408675A true BRPI0408675A (pt) 2006-03-28

Family

ID=33035142

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0408675-9A BRPI0408675A (pt) 2003-03-27 2004-03-04 derivados de talidomida solúveis em água

Country Status (12)

Country Link
US (1) US7741342B2 (pt)
EP (1) EP1607394B1 (pt)
JP (1) JP4703554B2 (pt)
CN (1) CN100488959C (pt)
AT (1) ATE479675T1 (pt)
AU (1) AU2004224271B2 (pt)
BR (1) BRPI0408675A (pt)
CA (1) CA2519051A1 (pt)
DE (1) DE602004028917D1 (pt)
ES (1) ES2349372T3 (pt)
WO (1) WO2004085422A1 (pt)
ZA (1) ZA200506797B (pt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1389203B8 (en) 2001-02-27 2010-03-10 The Governement of the United States of America, represented by The Secretary Department of Health and Human services Analogs of thalidomide as angiogenesis inhibitors
WO2005016326A2 (en) * 2003-07-11 2005-02-24 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Analogs of thalidomide as potential angiogenesis inhibitors
US8952895B2 (en) 2011-06-03 2015-02-10 Apple Inc. Motion-based device operations
CA2808646C (en) 2003-09-17 2016-08-23 The Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services Thalidomide analogs as tnf-alpha modulators
CN100383139C (zh) 2005-04-07 2008-04-23 天津和美生物技术有限公司 可抑制细胞释放肿瘤坏死因子的哌啶-2，6-二酮衍生物
MX361467B (es) * 2008-10-29 2018-12-06 Celgene Corp Compuestos de isoindolina para uso en el tratamiento de cancer.
US8927725B2 (en) 2011-12-02 2015-01-06 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Thio compounds
CN108101887A (zh) * 2016-11-24 2018-06-01 天津和美生物技术有限公司 哌啶-2,6-二酮衍生物及其在治疗克罗恩氏病中的用途
WO2019036839A1 (zh) * 2017-08-21 2019-02-28 诺瑞特国际药业股份有限公司 泊马度胺衍生物及其制备方法
CN111499610A (zh) * 2019-01-31 2020-08-07 南京诺瑞特医药科技有限公司 泊马度胺前体药物盐的多晶型物
CN110028439B (zh) * 2019-04-25 2020-11-13 四川大学 邻苯二甲酰亚胺类衍生物及其制备方法和用途

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU661299B2 (en) * 1991-04-17 1995-07-20 Grunenthal Gmbh New thalidomide derivatives, method of manufacture and use thereof in medicaments
DE19613976C1 (de) * 1996-04-09 1997-11-20 Gruenenthal Gmbh Thalidomid-Prodrugs mit immunmodulatorischer Wirkung
CN100383139C (zh) * 2005-04-07 2008-04-23 天津和美生物技术有限公司 可抑制细胞释放肿瘤坏死因子的哌啶-2，6-二酮衍生物

Also Published As

Publication number Publication date
CA2519051A1 (en) 2004-10-07
ES2349372T3 (es) 2010-12-30
EP1607394A1 (en) 2005-12-21
JP4703554B2 (ja) 2011-06-15
ZA200506797B (en) 2006-05-31
WO2004085422A1 (en) 2004-10-07
AU2004224271B2 (en) 2010-02-18
US7741342B2 (en) 2010-06-22
US20060094730A1 (en) 2006-05-04
CN100488959C (zh) 2009-05-20
JP2006521295A (ja) 2006-09-21
EP1607394A4 (en) 2008-06-25
CN1534035A (zh) 2004-10-06
DE602004028917D1 (de) 2010-10-14
AU2004224271A1 (en) 2004-10-07
EP1607394B1 (en) 2010-09-01
ATE479675T1 (de) 2010-09-15

Similar Documents

Publication Publication Date Title
ATE260255T1 (de) 5-oxo-pyrrolidine-2-carbonsäure- hydroxamidderivate
ATE223378T1 (de) Prolineamid-derivate
ATE126795T1 (de) Benzopyranderivate und verfahren zu ihrer herstellung.
MXPA02012034A (es) Derivados de tiofeno utiles como agentes anticancerosos.
NO20053644L (no) (2S)-2-[(4S)-4-(2,2-difluorvinyl)-2-oksopyrrolidinyl ]butanamid og farmasoytisk preparat
ATE321770T1 (de) Pseudoerythromycin-derivate
EP0767170A4 (en) Novel 4,6-diarylpyrimidine derivatives and salts thereof
ATE198743T1 (de) Imidazolidin-derivate und ihre verwendung
AR022469A1 (es) Uso de acidos isoxazolcarboxilicos sustituidos y derivados y nuevas sustancias
DE69820248D1 (de) Pyrrolidin-derivate die eine phospholipase-a2-hemmende wirkung haben
BRPI0408675A (pt) derivados de talidomida solúveis em água
MXPA03011954A (es) Nuevos derivados de acido sulfonico.
PT992509E (pt) Novos derivados macrolidos
AU8811401A (en) Spiro compounds and adhesion molecule inhibitors containing the same as the active ingredient
DE3882895D1 (de) Imid-derivate, ihre herstellung und verwendung.
ATE513821T1 (de) Thiadiazolin-derivate zur behandlung von krebs
ATE89739T1 (de) Entzuendungshemmende und/oder antiallergische zusammensetzung, die glutathionderivate enthaelt.
EP1434762A4 (en) 4'-methanesulfonyl-biphenyl derivatives as a highly selective cyclooxygenase-2 inhibitor
FI97883B (fi) Menetelmä lääkeaineena käyttökelpoisen glyserolijohdannaisen valmistamiseksi
DK0551844T3 (da) Svovlholdige galdesyrederivater
ATE247963T1 (de) Medikament zur behandlung von glaukoma und ischämischer retinopathie
DE60230924D1 (de) 2-substituierte vitamin-d-derivate
DE69908855D1 (de) 9a, 11b-dehydro Derivative von 9-oxime-3-keto-6-0-methylerythromycin
ATE380028T1 (de) Mittel zur anregung des appetits und mittel zur behandlung von anorexie
EA200501691A1 (ru) Новый промежуточный продукт для получения терапевтически активных имидазопиридинов

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 8A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2144 DE 07/02/2012.